Open-access The relationship between a body shape index and abdominal aortic calcification: a population-based study

Abstract

Background  Abdominal Aortic Calcification (AAC) is closely associated with visceral adiposity. The authors aimed to investigate the relationship between a Body Shape Index (ABSI) and AAC.

Methods  Data were obtained from the 2013‒2014 cycle of the National Health and Nutrition Examination Survey (NHANES). Weighted multivariable regression, tests for trends, subgroup analysis, and smooth curves were used to explore the association between ABSI and AAC scores, as well as Severe Abdominal Aortic Calcification (SAAC). Receiver Operating Characteristic (ROC) curves were plotted to compare the predictive abilities of ABSI, Weight-adjusted Waist Index (WWI), Body Mass Index (BMI), Waist-to-Height Ratio (WHtR), and Waist Circumference (WC) for AAC and SAAC.

Results  A total of 2741 individuals were included in the present study. The weighted incidence of AAC was 29.12%, and SAAC was 7.94%. After fully adjusting for covariates, each one-unit increase in ABSI was associated with a 0.42-point increase in the AAC score (95% CI: 0.29, 0.63), and the risk of SAAC increased by 37% (95% CI: 1.12, 1.77). Smooth curves showed a nonlinear positive correlation between ABSI and AAC scores, as well as SAAC. No dependence was observed in the subgroup analysis. ROC analysis showed that ABSI was a stronger predictor than WWI, BMI, WHtR, and WC.

Conclusions  ABSI has a positive correlation with AAC scores and SAAC. However, prospective studies are required to validate the present results.

Keywords
Cross-sectional research; Abdominal aortic calcification; Severe abdominal aortic calcification; A body shape index; NHANES

Introduction

Abdominal Aortic Calcification (AAC) is a pathological process in which minerals, such as calcium-phosphate complexes, are deposited in the vascular system, and vascular smooth muscle cells undergo osteogenic differentiation and mineralization in response to this stimulus.1,2 A cohort study indicated that the prevalence of AAC in males and females aged 55- to 64-years was 81.8 % and 5 9.1 %, respectively.3 Numerous factors contribute to AAC, such as dyslipidemia, diabetes, hormones, inflammatory factors, smoking, and old age.4,5 Obesity, especially abdominal obesity, is an important contributor to AAC. It was found that abdominal visceral adiposity content was significantly and positively correlated with AAC by computed tomography scanning studies (p = 0.006, α = 0.05). This relationship was still significant after adjusting for the effects of confounding variables, indicating that adiposity accumulation is an important factor in causing AAC.6 Jensky et al. demonstrated that an increase in the ratio of muscle tissue to fatty tissue reduced the incidence of AAC (OR = 0.7) and that fatty tissue was positively associated with prevalent aortic calcification.7 AAC, especially Severe Abdominal Aortic Calcification (SAAC), is a marker of vascular aging and cardiovascular diseases such as myocardial infarction, heart failure, and stroke.5 Epidemiologic studies have reported that SAAC can predict mortality in cardiovascular diseases.8

Although abdominal fatty accumulation is an important marker for predicting AAC, most of the current data on abdominal fat are obtained by computed tomography scanning, a method that is difficult to generalize because of its limitations, high cost, and radiation hazards to participants, especially pregnant women.9 A Body Shape Index (ABSI) is a new body index calculated by waist circumference, Body Mass Index (BMI), and height. High ABSI indicates that the waist circumference is higher than the standard height and weight, and compared to BMI, which is unable to differentiate between the accumulation of muscle and fat, ABSI is better able to reflect the accumulation of abdominal fat.10 It has been shown that ABSI has demonstrated an excellent ability to predict diabetes, cardiovascular events, frailty, and mortality in middle-aged and older adults,11-14 suggesting that ABSI may serve as a simple, noninvasive marker of adverse vascular phenotype. Although previous studies have explored the relationship between ABSI and AAC, important limitations remain. In particular, some prior analyses did not account for the complex sampling design of the National Health and Nutrition Examination Survey (NHANES), including the use of sampling weights, which is essential for generating unbiased, nationally representative estimates in U.S. adults. In addition, it is still unclear whether ABSI is associated not only with the presence of AAC but also with the overall calcification burden (AAC score) and with SAAC, and how this association changes across increasing ABSI levels. Therefore, using data from the NHANES 2013‒2014 survey cycle, the present study aimed to evaluate the association between ABSI and abdominal aortic calcification in a nationally representative sample of U.S. adults, including AAC presence, AAC score as a measure of calcification burden, and SAAC, while accounting for the complex NHANES sampling design.

Materials and methods

Study population

The National Health and Nutrition Examination Survey (NHANES) is administered by the National Center for Health Statistics (NCHS), and its Research Ethics Review Committee reviews and approves NHANES survey protocols (Protocol n° 2011-17). It is a nationally representative study that includes all age groups in the U.S.The data for this research were obtained from the NHANES 2013‒2014 survey cycle, which included 10,175 participants. After excluding participants with missing data ‒ 7035 with missing AAC scores, 63 with missing BMI and waist circumference, and 336 with missing covariates ‒ a total of 2741 participants were enrolled in this study (Fig. 1). This cross-sectional study follows the STROBE Statement.

Fig. 1
Flowchart of the study.

Evaluation of the AAC

NHANES performed spinal radiographs on people over 40-years of age and obtained AAC data from lateral spinal radiographs of the first through fourth lumbar vertebrae. The AAC was scored using the AAC-24 scoring semi-quantitative technique, with a total score ranging from 0 to 24. A score of 0 is no AAC; a score greater than 0 is considered AAC; and a score greater than 6 is considered SAAC.15 NCHS performs high-quality control of data collection and scan analysis. The ACC data collection process is described on the official NHANES website: https://www.cdc.gov/nchs/nhanes/.

Assessment of ABSI

The ABSI was calculated as BMI, waist circumference, and height, with BMI calculated as weight in kilograms divided by height in meters squared, waist circumference measurements were localized by bilateral iliac crests, and height was the maximum vertical height while standing. All measurements were done by trained health technicians and record keepers. The ABSI was calculated as waist circumference / (BMI 2/3 × height 1/2).11

Covariates

Based on previous studies, the covariates in this study were grouped into two categories. Demographic and lifestyle characteristics included age, gender, marital status, education level, race, alcohol consumption, and smoking. Clinical comorbidities and laboratory parameters included diabetes, hypertension, Coronary Heart Disease (CHD), stroke, cancer, arthritis, Chronic Obstructive Pulmonary Disease (COPD), liver condition, total calcium (mmoL/L), cholesterol (mmoL/L), triglycerides (mmoL/L), uric acid (µmoL/L), creatinine (µmoL/L), and 25-hydroxyvitamin-D3 (25(OH)D3) (nmoL/L). Detailed information on all covariates in this study can be accessed by visiting the NHANES database: https://www.cdc.gov/nchs/nhanes/.

Statistical analyses

This study was statistically analyzed using R software (version 4.3) and EmpowerStats (version 4.2). ABSI was categorized into quartiles, and differences between ABSI quartiles for each variable were compared. Continuous variables and categorical variables were expressed as mean ± standard deviation and proportions, respectively. If the continuous variables were normally distributed, t-tests were used; otherwise, Mann-Whitney U tests were applied. Categorical variables were analyzed using Chi-Square tests. The association between ABSI quartiles and AAC scores and SAAC was explored using multivariate linear regression and trend tests. Model 1 was not adjusted for any variables, Model 2 was adjusted for age, gender, marital status, race, and education level, and Model 3 further adjusted for alcohol consumption, smoking, diabetes, hypertension, CHD, stroke, cancer, arthritis, COPD, liver condition, total calcium, cholesterol, triglycerides, uric acid, creatinine, and (25(OH)D3) based on Model 2. A smooth curve was plotted to visualize the relationship between ABSI and AAC scores and SAAC. Subgroup analysis and interaction tests were performed by gender (male/female), diabetes (yes/no), and hypertension (yes/no). Considering the complex sampling characteristics of NHANES, sample weights were included in all the above analyses. Receiver Operating Characteristic (ROC) curves were plotted to compare the predictive ability of ABSI, Weight-Adjusted Waist Index (WWI), Body Mass Index (BMI), Waist-to-Height Ratio (WHtR), and Waist Circumference (WC). A p-value < 0.05 was considered statistically significant.

Results

Baseline characteristics

The present study included 2741 participants, with weighted percentages of 48.43 % for males and 51.57 % for females. The incidence rate of AAC was 29.12 %, and the incidence rate of SAAC was 7.94 %. The quartiles of ABSI were as follows: Q1 (0.06780‒0.08013), Q2 (0.08013‒0.08302), Q3 (0.08302‒0.08596), and Q4 (0.08596‒0.10795). Table 1 shows the differences in AAC score, AAC, and SAAC across the ABSI quartiles. Compared with the lowest quartile, participants in the highest ABSI quartile had significantly higher AAC scores and a higher prevalence of both AAC and SAAC (p < 0.05). Table 2 summarizes demographic and lifestyle characteristics across ABSI quartiles; age, gender, education level, race, alcohol consumption, and smoking all differed significantly across ABSI quartiles (all p < 0.05). Table 3 presents clinical comorbidities and laboratory parameters across ABSI quartiles, and significant differences were observed for cholesterol, triglycerides, uric acid, creatinine, 25(OH)D3, diabetes, hypertension, CHD, stroke, cancer, arthritis, COPD, and liver condition.

Table 1
AAC score, AAC, and SAAC across ABSI quartiles in the study population.
Table 2
Demographic and lifestyle characteristics of participants across ABSI quartiles.
Table 3
Clinical comorbidities and laboratory parameters of participants across ABSI quartiles.

Association between ABSI and AAC scores and SAAC

Table 4 reveals the association between ABSI and AAC scores. When ABSI is treated as a continuous variable, there is a positive correlation between ABSI and AAC scores across all models. Specifically, in Model 3, for each one-unit increase in ABSI, the AAC score increases by 0.42-points (95 % CI: 0.29, 0.63). Additionally, AAC scores increased with higher ABSI quartiles in all three models. In Model 3, compared to the first quartile, each 1-unit increase in the highest ABSI quartile was associated with a 0.87-point (95 % CI: 0.49, 1.25) increase in AAC scores. Table 5 shows that ABSI and SAAC were strongly positively correlated in all three models. When ABSI is treated as a continuous variable, in Model 3, each one-unit increase in ABSI is associated with a 37 % (95 % CI: 1.12, 1.77) higher incidence of SAAC. The risk of SAAC increased significantly with higher ABSI quartiles in all three models. In Model 3, the risk of SAAC in the highest ABSI quartile was 1.64 times (95 % CI: 1.56, 4.47) higher than in the lowest quartile. In both adjusted and unadjusted models, the p for trend was < 0.001, suggesting that as ABSI quartiles increased, both AAC scores and the incidence of SAAC notably increased. Smooth curves demonstrated a nonlinear positive correlation between ABSI and both AAC scores and SAAC (Fig. 2).

Table 4
Associations between ABSI and AAC scores.
Table 5
Associations between ABSI and SAAC.

Fig. 2
Smooth curves association between ABSI and AAC scores and SAAC. The red line represents the smooth curve fit between ABSI and AAC. Blue line bands represent 95 % Confidence Intervals of the fit. (A) ABSI and AAC score. (B) ABSI and SAAC.

Subgroup analysis

To assess the consistency of the nonlinear positive correlation of ABSI with AAC scores and SAAC in the population, the authors performed subgroup analysis and interaction tests by gender (male/female), diabetes (yes/no), and hypertension (yes/no), and only observed a positive correlation between ABSI and AAC scores in the hypertensive population (OR = 2.24, 95 % CI 1.32‒4.45). The overall results of the subgroup analysis showed that the positive association of ABSI with AAC scores and SAAC was independent of gender, diabetes, and hypertension (p for interaction > 0.05) (Fig. 3).

Fig. 3
Forest plots of subgroup analysis according to model 3. (A) Subgroup analysis between ABSI and AAC scores. (B) Subgroup analysis between ABSI and SAAC.

The predictive ability of the ABSI

The ROC curves showed that the Area Under the Curves (AUCs) of ABSI, WWI, BMI, WHtR, and WC were 0.628, 0.596, 0.548, 0.490, and 0.505 in predicting AAC, and 0.677, 0.649, 0.575, 0.523, and 0.520 in predicting SAAC (Fig. 4). ABSI had the highest AUC for both predictions, indicating that ABSI has valuable predictive ability.

Fig. 4
ABSI, WWI, BMI, WHtR, and WC predict ROC curves for AAC and SAAC. (A) ROC curve in AAC. (B) ROC curve in SAAC.

Discussion

Through a weighted analysis of 2741 participants, the present study found that ABSI was positively correlated with AAC scores and SAAC after fully adjusting for covariates, suggesting that individuals with higher ABSI are more likely to develop AAC and SAAC. Additionally, ROC analysis revealed that AISI had stronger predictive ability for AAC and SAAC compared to WWI, BMI, WHtR, and WC.

Previous studies have shown a close correlation between abdominal fat accumulation and AAC.16-18 Through analysis of abdominopelvic CT in 302 participants, Ivan et al. reported that AAC was significantly and positively correlated with the amount of visceral adipose tissue and that the abdominal aorta was the most calcified vessel compared to other abdominal vessels (6). A prospective study showed that visceral obesity was independently associated with the severity of AAC (OR = 6.63, 95 % CI 1.90‒23.14), indicating that visceral obesity may have a contributory effect on AAC.19 Cross-sectional studies have found that visceral obesity is positively associated with both AAC scores and SAAC (β = 0.04, 95 % CI 0.01‒0.08; OR = 1.04, 95 % CI 1.01‒1.07) and that this correlation is independent of sex, age, BMI, hypertension, and diabetes.20 Compared to the disadvantage of BMI, which does not distinguish between muscle and adipose tissue, the ABSI calculation takes into account the relationship between height, weight, and waist circumference and therefore better reflects the amount of abdominal fat accumulation in individuals.10,21 The present study showed that the ability of ABSI to predict AAC and SAAC was better than that of WWI, BMI, WHtR, and WC, which is consistent with other studies. Existing studies have indicated that ABSI is a better predictor of diabetes, cardiovascular disease, hypertension, and all-cause mortality than BMI.11,22-24 Ning et al. reported that the change in ABSI was associated with mortality among people aged 65-years or older in China, with each 10 % increase in ABSI increasing the risk of death in the study population by 1.9 %.25 In the present study, after fully adjusting covariates, ABSI still shows a strong positive correlation with AAC score and SAAC, and the smooth curves visualize this relationship, suggesting that ABSI is a valuable predictor of AAC and SAAC.

In addition, the subgroup analysis indicated that the positive association between ABSI and AAC was more pronounced among individuals with hypertension. This is consistent with prior evidence that the occurrence of AAC in hypertensive patients is approximately 1.66-times that of non-hypertensive individuals (OR = 1.66, 95 % CI 1.30-2.13), suggesting that elevated blood pressure may amplify the impact of abdominal adiposity on vascular calcification.26 Although the underlying mechanism is not yet fully understood, it has been proposed that long-term hypertension may promote AAC by inducing hemodynamic stress and endothelial injury in the aortic wall, thereby accelerating vascular remodeling and calcific degeneration.27

Fewer studies have been conducted to investigate the mechanisms of abdominal obesity and AAC. Adipose tissue has been reported to secrete adiponectin, leptin, Tumor Necrosis Factor-alpha (TNF-a), and Interleukin-6 (IL-6), which can cause insulin resistance, endothelial dysfunction, and promote arterial calcification.28,29 Panagiotis et al. reported that adipose tissue secretes adipokines leptin, adiponectin, and other adipokines, of which leptin has a thrombogenic effect that promotes vascular inflammation and increases oxidative stress through leptin receptors, a process that can lead to the formation of arterial calcification, and adiponectin can inhibit the macrophages into foam cells and reduce their phagocytic activity, causing arterial calcification.30 However, the exact mechanism by which abdominal fat leads to AAC calcification is not fully understood due to a lack of research; further studies are needed to elucidate it.

Although several studies have investigated the relationship between ABSI and AAC, the existing literature still has notable limitations. For example, most studies did not examine the association between ABSI and SAAC, were based on relatively small sample sizes, and did not incorporate sampling weights to achieve population-level representativeness. In this context, the present study advances the field in several ways. Using data from NHANES 2013-2014, the authors evaluated the relationship between ABSI and both AAC scores and SAAC in a nationally representative U.S. adult population. The authors further visualized the dose-response pattern between ABSI and AAC/SAAC using smooth curves, and the authors conducted subgroup analyses to explore the stability of this association across clinically relevant strata. These strengths enhance the interpretability and relevance of the present findings. This study also has some limitations: First, NHANES only assessed AAC in participants aged 40-years and older, so individuals under 40-years of age were not included. Therefore, it is unclear whether these findings can be generalized to younger populations. Second, because this is not a longitudinal cohort study, the authors cannot establish a causal relationship between ABSI and AAC/SAAC. Prospective studies are needed to determine temporality and to evaluate whether changes in ABSI over time correspond to the progression of aortic calcification.

The strong association between ABSI and AAC/SAAC suggests that this easily calculated index could be integrated into public health strategies for primary prevention. In clinical and community settings, ABSI could serve as a simple, low-cost tool to identify individuals with high central adiposity who may be at increased risk of subclinical vascular disease. Early identification of these high-risk individuals would allow timely and targeted lifestyle interventions, such as promoting physical activity, weight management, and dietary patterns that reduce visceral fat, with the goal of preventing or delaying vascular calcification and subsequent cardiovascular complications at the population level.

Conclusions

The present findings suggest that ABSI is nonlinearly and positively related to AAC scores and SAAC, indicating its potential predictive value for both conditions. However, future longitudinal studies are needed to confirm these relationships.

Availability of data and materials

All data in this study can be accessed by visiting the official NHANES website: https://www.cdc.gov/nchs/nhanes/.

Ethics approval and consent to participate

NHANES was approved by the Ethics Review Board of the NCHS (Protocol n° 2011-17). The study was performed in accordance with the principles of the Declaration of Helsinki. Participants provided written informed consent.

  • Funding
    This work was supported by the National Natural Science Foundation of China: 81960091, and Prof. Xiao Qin from the First Affiliated Hospital of Guangxi Medical University is the recipient.

Data availability

The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Acknowledgment

The authors thank the NHANES researchers and acknowledge participants for their contributions.

References

  • 1 Chen Y., Zhao X., Wu H. Arterial stiffness: a focus on vascular calcification and its link to bone mineralization. Arterioscler Thromb Vasc Biol. 2020;40(5):1078-93.
  • 2 Lee S.J., Lee I.K., Jeon J.H. Vascular calcification-new insights into its mechanism. Int J Mol Sci. 2020;21(8):2685.
  • 3 Chuang M.L., Massaro J.M., Levitzky Y.S., Fox C.S., Manders E.S., Hoffmann U., et al. Prevalence and distribution of abdominal aortic calcium by gender and age group in a community-based cohort (from the Framingham Heart Study). Am J Cardiol. 2012;110(6):891-6.
  • 4 Jayalath R.W., Mangan S.H., Golledge J. Aortic calcification. Eur J Vasc Endovasc Surg. 2005;30(5):476-88.
  • 5 Golledge J. Abdominal aortic calcification: clinical significance, mechanisms and therapies. Curr Pharm Des. 2014;20(37):5834-8.
  • 6 Ordulj I., Šarić F., Tandara M., Jerković K., Lovrić Kojundžić S., Marinović Guić M., et al. Visceral and ectopic abdominal fat effect on the calcification of the abdominal aorta and its branches-an MSCT study. Life (Basel). 2023;14(1):2.
  • 7 Jensky N.E., Criqui M.H., Wright C.M., Wassel C.L., Alcaraz J.E., Allison M.A. The association between abdominal body composition and vascular calcification. Obesity (Silver Spring). 2011;19(12):2418-24.
  • 8 Hoffmann U., Massaro J.M., D'Agostino R.B., Sr., Kathiresan S., Fox C.S., O'Donnell C.J. Cardiovascular event prediction and risk reclassification by coronary, aortic, and valvular calcification in the Framingham Heart Study. J Am Heart Assoc. 2016;5(2):e003144.
  • 9 Goldenberg L., Saliba W., Hayeq H., Hasadia R., Zeina A.R. The impact of abdominal fat on abdominal aorta calcification measured on non-enhanced CT. Medicine. 2018;97(49):e13233.
  • 10 Krakauer N.Y., Krakauer J.C. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504.
  • 11 Bawadi H., Abouwatfa M., Alsaeed S., Kerkadi A., Shi Z. Body shape index is a stronger predictor of diabetes. Nutrients. 2019;11(5):1018.
  • 12 Kajikawa M., Maruhashi T., Kishimoto S., Yamaji T., Harada T., Saito Y., et al. A body shape index as a simple anthropometric marker of abdominal obesity and risk of cardiovascular events. J Clin Endocrinol Metab. 2024;109(12):3272-81.
  • 13 Shafran I., Krakauer N.Y., Krakauer J.C., Goshen A., Gerber Y. The predictive ability of ABSI compared to BMI for mortality and frailty among older adults. Front Nutr. 2024;11:1305330.
  • 14 Dhana K., Kavousi M., Ikram M.A., Tiemeier H.W., Hofman A., Franco O.H. Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality. J Epidemiol Community Health. 2016;70(1):90-6.
  • 15 Kauppila L.I., Polak J.F., Cupples L.A., Hannan M.T., Kiel D.P., Wilson P.W. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis. 1997;132(2):245-50.
  • 16 Rosito G.A., Massaro J.M., Hoffmann U., Ruberg F.L., Mahabadi A.A., Vasan R.S., et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117(5):605-13.
  • 17 Ozturk C., Gungor O., Kaplanoglu V., Kasikci M., Ramadan S.U. Relationship between abdominal aortic calcification, abdominal adiposity, and liver density. J Coll Physicians Surg Pak. 2020;30(12):1245-50.
  • 18 Fox C.S., Hwang S.J., Massaro J.M., Lieb K., Vasan R.S., O'Donnell C.J., et al. Relation of subcutaneous and visceral adipose tissue to coronary and abdominal aortic calcium (from the Framingham Heart Study). Am J Cardiol. 2009;104(4):543-7.
  • 19 Golledge J., Jayalath R., Oliver L., Parr A., Schurgers L., Clancy P. Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. Atherosclerosis. 2008;197(1):428-34.
  • 20 Qin Z., Jiang L., Sun J., Geng J., Chen S., Yang Q., et al. Higher visceral adiposity index is associated with increased likelihood of abdominal aortic calcification. Clinics (Sao Paulo). 2022;77:100114.
  • 21 Nevill A.M., Stewart A.D., Olds T., Holder R. Relationship between adiposity and body size reveals limitations of BMI. Am J Phys Anthropol. 2006;129(1):151-6.
  • 22 Corbatón-Anchuelo A., Krakauer J.C., Serrano-García I., Krakauer N.Y., Martínez-Larrad M.T., Serrano-Ríos M. A body shape index (ABSI) and hip index (HI) adjust waist and hip circumferences for body mass index, but only ABSI predicts high cardiovascular risk in the Spanish caucasian population. Metab Syndr Relat Disord. 2021;19(6):352-7.
  • 23 Lu C.Y., Chen H.H., Chi K.H., Chen P.C. Obesity indices and the risk of total and cardiovascular mortality among people with diabetes: a long-term follow-up study in Taiwan. Cardiovasc Diabetol. 2023;22(1):345.
  • 24 Ji M., Zhang S., An R. Effectiveness of A Body Shape Index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis. Obes Rev. 2018;19(5):737-59.
  • 25 Yang N., Zhuo J., Xie S., Qu Z., Li W., Li Z., et al. A body shape index and its changes in relation to all-cause mortality among the Chinese elderly: a retrospective cohort study. Nutrients. 2023;15(13):2943.
  • 26 Rahman E.U., Chobufo M.D., Farah F., Elhamdani A., Khan A., Thompson E.A., et al. Prevalence and risk factors for the development of abdominal aortic calcification among the US population: NHANES study. Arch Med Sci Atheroscler Dis. 2021;6:e95-e101.
  • 27 Boutouyrie P., Chowienczyk P., Humphrey J.D., Mitchell G.F. Arterial stiffness and cardiovascular risk in hypertension. Circ Res. 2021;128(7):864-86.
  • 28 Ritchie S.A., Connell J.M. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17(4):319-26.
  • 29 Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821-30.
  • 30 Kougias P., Chai H., Lin P.H., Yao Q., Lumsden A.B., Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res. 2005;126(1):121-9.

Edited by

  • Edited by:
    José Maria Soares Junior

Publication Dates

  • Publication in this collection
    18 May 2026
  • Date of issue
    2026

History

  • Received
    29 Aug 2025
  • Reviewed
    19 Nov 2025
  • Accepted
    31 Dec 2025
  • Published
    25 Mar 2026
location_on
Faculdade de Medicina / USP Rua Dr Ovídio Pires de Campos, 225 - 6 and., 05403-010 São Paulo SP - Brazil, Tel.: (55 11) 2661-6235 - São Paulo - SP - Brazil
E-mail: clinics@hc.fm.usp.br
rss_feed Acompanhe os números deste periódico no seu leitor de RSS
Ir para o topo Reportar erro